Pfizer Inc. XNYS: PFE

Mid-range Performer

Download real time

26.81 -0.24 (-0.89%)

Near 52W High of $27.94

42.7M

XNYS Volume

XNYS 09 Mar, 2026 5:30 PM (EDT)

Drug Approval

China approves Pfizer GLP-1 drug ecnoglutide for weight loss, boosting rivalry with Novo and Lilly See details

Pfizer quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents